Acacia Pharma, which is focused on the development and commercialization of new products to treat and prevent nausea and vomiting suffered by surgical and cancer patients, is planning to raise new funds through an Initial Global Offering with admission of all of its ordinary shares to trading on Euronext Brussels. 5 February 2018
On February 1, 2018, Bi Jingquan, Minister of the China Food and Drug Administration (CFDA), met with the visiting Dr Ian Hudson, the chief executive of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), and his delegation. 5 February 2018
Japanese drug major Astellas Pharma (TYO: 4503) has announced that its board of directors approved a change in its representative director, president and chief executive naming Kenji Yasukawa to the post. 1 February 2018
German family-owned pharma major Boehringer Ingelheim announced today that Paul Fonteyne, US president and chief executive, will retire after 15 years of service on December 31, 2018. 31 January 2018
Amryt Pharma, a UK biopharmaceutical company focused on rare and orphan diseases, is pleased to announce that it has signed an exclusive distribution agreement for Lojuxta (lomitapide) covering Romania and Bulgaria with Romastru Trading. 31 January 2018
The US Food and Drug Administration is launching a new set of web pages that aims to provide a one-stop source for general information about Risk Evaluation and Mitigation Strategy (REMS) programs. 30 January 2018
Long-time Celgene executive chairman Bob Hugin has retired, the firm has announced. Chief executive Mark Alles will take on the new role of chairman. 30 January 2018
The European Commission (EC) has granted marketing authorization for Prevymis (letermovir) as an orphan medicinal product for prophylaxis (prevention) of cytomegalovirus (CMV) reactivation and disease in adult CMV-seropositive recipients [R+] of an allogeneic hematopoietic stem cell transplant (HSCT). 29 January 2018
Metrion Biosciences, the specialist ion channel contract research and drug discovery company, has acquired a portfolio of more than 2,000 small molecule potassium channel inhibitors from Japan Tobacco. 29 January 2018
Swedish firm Follicum today announced that it has successfully mapped the receptors in insulin-producing cells that bind the company’s peptides. 29 January 2018
As well as recommending seven medicines for approval at its January 2018 meeting, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued some negative opinions. 27 January 2018
Global law firm Hogan Lovells has publishes its second annual Global IP Outlook, providing a unique snapshot of the challenges and opportunities facing intellectual property owners around the world. 26 January 2018
Brazil yesterday launched a mass immunization campaign that will deliver fractional doses of yellow fever vaccine to residents of 69 municipalities in the states of Rio de Janeiro and São Paulo. 26 January 2018
US healthcare giant Johnson & Johnson is out of the running to buy the consumer health business of the world’s biggest pharma company, Reuters reports. 25 January 2018
Boehringer Ingelheim today announced results from a retrospective, observational real-world study assessing the safety and effectiveness of novel oral anticoagulants (NOACs) among patients with non-valvular atrial fibrillation (NVAF) treated through the US Department of Defense Military Health System. 25 January 2018
Switzerland’s medicines regulator Swissmedic has accepted for review Mitsubishi Tanabe’s regulatory filing for edaravone to treat the neurological disease amyotrophic lateral sclerosis (ALS). 25 January 2018
UK-based cannabinoid specialist GW Pharmaceuticals has published results from its study into lead candidate Epidiolex in patients with Lennox-Gastaut syndrome (LGS). 25 January 2018
Gan & Lee Pharmaceuticals as reported that its three investigational drugs - GZR18, GZR4, and GZR101 - achieved positive results in Phase II diabetes trials. 17 October 2024
A new group of British Members of Parliament (MPs) and peers have written to the Chancellor urging her to protect and promote the UK’s world-leading life sciences sector in the government's first Budget, due on October 30. 17 October 2024
The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza Vaccine) to include data from a new safety study involving pregnant women. 17 October 2024
Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma giant Novartis for a small molecule anti-tumor asset. 17 October 2024
Shionogi has announced new data at IDWeek 2024 from PROVE (Retrospective Cefiderocol Chart Review), the largest global real-world evidence study of Fetroja/Fetcroja (cefiderocol), an innovative siderophore cephalosporin. 17 October 2024
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
ViiV Healthcare, the specialist HIV company majority owned by GSK, today announced the presentation of new real-world evidence and implementation data showing the effectiveness, adherence, and quality-of-life improvement of Apretude (cabotegravir long-acting (CAB LA)) for HIV pre-exposure prophylaxis (PrEP). 16 October 2024
Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration (FDA)-approved mucoadhesive on the market indicated for the management of pain caused by oral mucositis 16 October 2024
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
US pharma major Eli Lilly has announced a strategic collaboration with two UK government departments and the devolved nations to tackle significant population health challenges, including exploring new models to better care for people living with obesity. 16 October 2024
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Switzerland-based Novocure saw its shares rise 10% yesterday and leap a further 24% to $22.05 pre-market, after the company received a new US regulatory approval for its key product Optune Lua. 16 October 2024
Shares of Spanish drugmaker PharmaMar leapt more than 28% to 63.70 euros today, after it announced positive clinical trial findings for its combo lung cancer treatment, under development with USA-based Jazz Pharmaceuticals, which rose 4.2%. 15 October 2024
Novartis has discontinued an early Phase II trial of LTP001 in idiopathic pulmonary fibrosis (IPF). The company confirmed that the decision was not related to safety, with no issues emerging in the study. 15 October 2024
US pharma major Eli Lilly has announced plans to invest around 1.5 billion renminbi ($206 million) into expanding its manufacturing facility in Suzhou, China. 15 October 2024
Spanish dermatology specialist Almirall (BME: ALM) has announced the successful completion of the decentralized regulatory procedure in Europe for efinaconazole. 15 October 2024
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024